New findings just published in the New England Journal of Medicine show the drug, Risperdal is roughly twice as effective as its older cousin, Haldol, in treating schizophrenia symptoms. Researchers in Saint Louis compared to the two medications in more than 350 patients. They found that among the ones who took Risperdal for at least a year, relapse rates dropped to 48%. Until now, Haldol has been considered the gold standard treatment for Schizophrenia.
High speed technology comes to the laboratory, as a new device dramatically cuts the amount of time researchers have to wait for test results. The applied bio systems group has unveiled the 4700 Proteomics Analyzer. It's able to identify and characterize protein samples at a rate of up to 1,000 per hour, a ten-fold increase over current analyzers. Such speed will help scientists sift through more samples as they work to understand and the role proteins play in diseases and drug therapies.
So called "Winter Depression" may be our way of mimicking a mammal's need to hibernate in the winter. That's the word of researchers who studied more than 100 people, half of whom suffered from seasonal affective disorder. It's a psychiatric disorder that strikes during winter months when there are fewer hours of daylight. Experts found that people with the disorder instinctively shifted their brain's Melatonin levels with the seasons, similar to the hibernation patterns of mammals. Melatonin is the hormone that helps to regulate our body clocks.